Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Bup: High vs Standard Dose Buprenorphine for OUD
NCT06316830Phase 3Recruiting
- Sponsor
- Rhode Island Hospital
- Start
- Jan 2025
- Primary completion
- Aug 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of buprenorphine in opioid use disorder (OUD), sponsored by Rhode Island Hospital. Started Jan 2025; status: recruiting.
02
Drugs
buprenorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT06316830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06316830.